5 (272) In stock
FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
Quarterly Update Diabetes Technology
Medtronic buys EOFlow for its wearable insulin patch technology
Comparison of Automated Insulin Delivery Systems
Savvy Updates, 4/1/19: Beta Cell Destruction, Patch Pumps
Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App
Quarterly Update Diabetes Technology
Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)
Omnipod CGM and Pump Patch - Diabetes UK Shop
3 Updates on Diabetes Technology You Don't Want to Miss
Insulet, Abbott earn EU nod for artificial pancreas system
Savvy Updates, 4/1/19: Beta Cell Destruction, Patch Pumps (EoPancreas & CellNovo), Integrated Medical Sensors, Insulin Dosing and AI, Hospital-based AP
Comparison of Automated Insulin Delivery Systems
Diabetes Device Development
